{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:20:28Z","timestamp":1793222428488,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG042178"],"award-info":[{"award-number":["R01AG042178"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG047812"],"award-info":[{"award-number":["R01AG047812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS105473"],"award-info":[{"award-number":["R01NS105473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41AG060836"],"award-info":[{"award-number":["R41AG060836"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001027","name":"CH Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016183","name":"Garrison Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.mcn.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T03:04:30Z","timestamp":1552359870000},"page":"47-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["Small molecules as therapeutic drugs for Alzheimer's disease"],"prefix":"10.1016","volume":"96","author":[{"given":"Darryll M.A.","family":"Oliver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Hemachandra","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mcn.2019.03.001_bb0005","doi-asserted-by":"crossref","first-page":"a012641","DOI":"10.1101\/cshperspect.a012641","article-title":"The maintenance of mitochondrial DNA integrity\u2014critical analysis and update","volume":"5","author":"Alexeyev","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.mcn.2019.03.001_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01605","article-title":"Diverse roles of mitochondria in immune responses: novel insights into Immuno-metabolism","volume":"9","author":"Angajala","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcn.2019.03.001_bb0015","doi-asserted-by":"crossref","unstructured":"Apak R, Guclu K, Demirata B, Ozyurek M, Celik SE, Bektasoglu B, Berker KI, Ozyurt (2007) Comparative evaluation of various total antioxidant capacity assays applied to phenolic compounds with the CUPRAC assay. Molecules. 12(7):1496\u20131547 doi:https:\/\/doi.org\/10.3390\/12071496.","DOI":"10.3390\/12071496"},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/ars.2014.5952","article-title":"Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications","volume":"22","author":"Apostolova","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.mcn.2019.03.001_bb0025","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.apsb.2018.05.006","article-title":"Park SJ (2018) mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives","volume":"8","author":"Battogtokh","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mcn.2019.03.001_bb0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yjmcc.2014.09.023","article-title":"The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection","volume":"78","author":"Bernardi","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.mcn.2019.03.001_bb0035","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bbabio.2015.06.006","article-title":"Disruption of cytochrome c heme coordination is responsible for mitochondrial injury during ischemia","volume":"1847","author":"Birk","year":"2015","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Bioenergetics"},{"issue":"1","key":"10.1016\/j.mcn.2019.03.001_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jnc.13033","article-title":"The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease","volume":"133","author":"Blair","year":"2015","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.mcn.2019.03.001_bb0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ijnp\/pyx012","article-title":"Discontinuation, efficacy, and safety of cholinesterase inhibitors for Alzheimer's disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16 106 patients","volume":"20","author":"Blanco-Silvente","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.mcn.2019.03.001_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2016.00024","article-title":"Alterations in mitochondrial quality control in Alzheimer's disease","volume":"10","author":"Cai","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"23","key":"10.1016\/j.mcn.2019.03.001_bb0055","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","article-title":"Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease","volume":"20","author":"Calkins","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.mcn.2019.03.001_bb0060","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","article-title":"Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease","volume":"19","author":"Caspersen","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.mcn.2019.03.001_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","article-title":"Mitochondrial diseases of the brain","volume":"63","author":"Chaturvedi","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mcn.2019.03.001_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00018-003-3206-5","article-title":"Diversity of structures and properties among catalases","volume":"61","author":"Chelikani","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.mcn.2019.03.001_bb0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/ijms18030545","article-title":"More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2019.03.001_bb0080","doi-asserted-by":"crossref","unstructured":"Cragg GM, Pezzuto JM (2015) Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventative agents. Medical Principles and Practice 2016. 25(suppl 2):41\u201359 DOI: https:\/\/doi.org\/10.1159\/000443404.","DOI":"10.1159\/000443404"},{"key":"10.1016\/j.mcn.2019.03.001_bb0085","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2147\/IJN.S131973","article-title":"Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective","volume":"12","author":"Davatgaran-Taghipour","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.mcn.2019.03.001_bb0090","doi-asserted-by":"crossref","unstructured":"Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., Gunn-Moore, F. J., Vonsattel, J. P., Arancio, O., Chen, J. X., \u2026 Yan, S. D. (2008). Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med., 14(10), 1097\u2013105.","DOI":"10.1038\/nm.1868"},{"issue":"43","key":"10.1016\/j.mcn.2019.03.001_bb0095","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.mcn.2019.03.001_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/acs.chemrestox.7b00311","article-title":"The double-edged sword profile of redox signaling: oxidative events as molecular switches in the balance between cell physiology and Cancer","volume":"31","author":"Emanuele","year":"2018","journal-title":"Chem. Res. Toxicol."},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/cns.12095","article-title":"Amyloid \u03b2, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?","volume":"19","author":"Esposito","year":"2013","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"5","key":"10.1016\/j.mcn.2019.03.001_bb0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.biotechadv.2012.09.005","article-title":"Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing","volume":"31","author":"Gruber","year":"2013","journal-title":"Biotechnol. Adv."},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.bbadis.2013.04.005","article-title":"Lysine deacetylases and mitochondrial dynamics in neurodegeneration","volume":"1832","author":"Guedes-Dias","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.mcn.2019.03.001_bb0120","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2016.07.071","article-title":"Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neurons","volume":"478","author":"Hu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0125","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1007\/s12035-016-0117-7","article-title":"A Mitocentric view of Alzheimer's disease","volume":"54","author":"Hu","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.mcn.2019.03.001_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"key":"10.1016\/j.mcn.2019.03.001_bb0135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.micro.57.030502.090938","article-title":"Pathways of oxidative damage","volume":"57","author":"Imlay","year":"2003","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.mcn.2019.03.001_bb0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1196\/annals.1427.036","article-title":"The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration","volume":"1147","author":"Johnson","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mcn.2019.03.001_bb0145","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.redox.2014.05.006","article-title":"Mitochondrial reactive oxygen species: a double edged sword in ischemia\/reperfusion vs preconditioning","volume":"2","author":"Kalogeris","year":"2014","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.mcn.2019.03.001_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer's disease: cellular and molecular mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci."},{"issue":"10","key":"10.1016\/j.mcn.2019.03.001_bb0155","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.3390\/ijms19102937","article-title":"Ageing, cellular senescence and neurodegenerative disease","volume":"19","author":"Kritsilis","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.mcn.2019.03.001_bb0160","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1093\/hmg\/ddx226","article-title":"Aqua-soluble DDQ reduces the levels of Drp1 and A\u03b2 and inhibits abnormal interactions between A\u03b2 and Drp1 and protects Alzheimer's disease neurons from A\u03b2- and Drp1-induced mitochondrial and synaptic toxicities","volume":"26","author":"Kuruva","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.mcn.2019.03.001_bb0165","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/j.bmc.2018.07.031","article-title":"SIRT4 is the last puzzle of mitochondrial sirtuins","volume":"26","author":"Li","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.mcn.2019.03.001_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2017.02.016","article-title":"Daphnetin-mediated Nrf2 antioxidant signaling pathways ameliorate tert-butyl hydroperoxide (t-BHP)-induced mitochondrial dysfunction and cell death","volume":"106","author":"Lv","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.mcn.2019.03.001_bb0175","doi-asserted-by":"crossref","first-page":"16484","DOI":"10.3390\/ijms150916484","article-title":"A review of pinealectomy-induced melatonin-deficient animal models for the study of etiopathogenesis of adolescent idiopathic scoliosis","volume":"15","author":"Man","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.mcn.2019.03.001_bb0180","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1093\/hmg\/dds360","article-title":"Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.mcn.2019.03.001_bb0185","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/hmg\/dds072","article-title":"Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl. 2","key":"10.1016\/j.mcn.2019.03.001_bb0190","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.3233\/JAD-2010-100564","article-title":"Mitochondria-targeted antioxidants protect against Abeta toxicity in Alzheimer's disease neurons","volume":"20","author":"Manczak","year":"2010","journal-title":"Journal of Alzheimer's Disease: JAD."},{"issue":"13","key":"10.1016\/j.mcn.2019.03.001_bb0195","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"23","key":"10.1016\/j.mcn.2019.03.001_bb0200","first-page":"5148","article-title":"Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease","volume":"25","author":"Manczak","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0205","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/hmg\/ddy042","article-title":"Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease","volume":"27","author":"Manczak","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.mcn.2019.03.001_bb0210","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0022-3565(24)29435-0","article-title":"Acute ethanol administration Oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants","volume":"298","author":"Mansouri","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"13","key":"10.1016\/j.mcn.2019.03.001_bb0215","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/hmg\/dds128","article-title":"Mitochondria-targeted catalase reduces abnormal APP processing, amyloid \u03b2 production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension","volume":"21","author":"Mao","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.mcn.2019.03.001_bb0220","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbadis.2013.09.005","article-title":"MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"1832","author":"Mao","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.mcn.2019.03.001_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123289","article-title":"Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis","volume":"10","author":"Matsunaga","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mcn.2019.03.001_bb0230","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/arclin\/acw049","article-title":"Assessment of activities of daily living, self-care, and Independence","volume":"31","author":"Mlinac","year":"2016","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"1","key":"10.1016\/j.mcn.2019.03.001_bb0235","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12035-016-0317-1","article-title":"Alpha-synuclein alters differently gene expression of Sirts, PARPs and other stress response proteins: implications for neurodegenerative disorders","volume":"55","author":"Motyl","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2019.03.001_bb0240","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.mcn.2019.03.001_bb0245","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.mcn.2019.03.001_bb0250","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.mcn.2019.03.001_bb0255","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.mcn.2019.03.001_bb0260","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.mcn.2019.03.001_bb0265","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.mcn.2019.03.001_bb0270","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.mcn.2019.03.001_bb0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0898-8838(00)51001-0","article-title":"Enzymology and structure of catalases","volume":"51","author":"Nicholls","year":"2001","journal-title":"Adv. Inorg. Chem."},{"issue":"3","key":"10.1016\/j.mcn.2019.03.001_bb0280","article-title":"Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for Mitochondrially targeted antioxidant therapeutics","volume":"2006","author":"Reddy","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.mcn.2019.03.001_bb0285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12017-008-8044-z","article-title":"Mitochondrial medicine for aging and neurodegenerative diseases","volume":"10","author":"Reddy","year":"2008","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.mcn.2019.03.001_bb0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.mcn.2019.03.001_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.mcn.2019.03.001_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/156720511795745401","article-title":"Mitochondria as a therapeutic target for aging and neurodegenerative diseases","volume":"8","author":"Reddy","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"1\u20132","key":"10.1016\/j.mcn.2019.03.001_bb0305","first-page":"103","article-title":"Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases","volume":"67","author":"Reddy","year":"2010","journal-title":"Brain Res. Rev."},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0310","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/jim-2016-000240","article-title":"Protective effects of a natural product, curcumin, against amyloid \u03b2 induced mitochondrial and synaptic toxicities in Alzheimer's disease","volume":"64","author":"Reddy","year":"2016","journal-title":"Journal of investigative medicine: the official publication of the American Federation for Clinical Research"},{"issue":"1","key":"10.1016\/j.mcn.2019.03.001_bb0315","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-170051","article-title":"Mitochondria-division inhibitor 1 protects against amyloid-\u03b2 induced mitochondrial fragmentation and synaptic damage in Alzheimer's disease","volume":"58","author":"Reddy","year":"2017","journal-title":"Journal of Alzheimer's disease: JAD"},{"issue":"2017","key":"10.1016\/j.mcn.2019.03.001_bb0320","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.pmbts.2016.12.009","article-title":"Chapter five \u2013 MicroRNAs, aging, cellular senescence, and Alzheimer's disease","volume":"146","author":"Reddy","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"4","key":"10.1016\/j.mcn.2019.03.001_bb0325","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3233\/JAD-170988","article-title":"Synergistic protective effects of mitochondrial division inhibitor 1 and mitochondria-targeted small peptide SS31 in Alzheimer's disease","volume":"62","author":"Reddy","year":"2018","journal-title":"Journal of Alzheimer's disease: JAD"},{"issue":"3","key":"10.1016\/j.mcn.2019.03.001_bb0330","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-170512","article-title":"Protective effects of Indian spice curcumin against amyloid Beta in Alzheimer's disease","volume":"61","author":"Reddy","year":"2018","journal-title":"Journal of Alzheimer's Disease: JAD"},{"issue":"6","key":"10.1016\/j.mcn.2019.03.001_bb0335","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1515\/revneuro-2017-0063","article-title":"Amyloid toxicity in Alzheimer's disease","volume":"29","author":"Reiss","year":"2018","journal-title":"Rev. Neurosci."},{"issue":"5730","key":"10.1016\/j.mcn.2019.03.001_bb0340","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1126\/science.1106653","article-title":"Extension of murine life span by overexpression of catalase targeted to mitochondria","volume":"308","author":"Schriner","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.mcn.2019.03.001_bb0345","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/bse0470085","article-title":"Mitochondrial fission and fusion","volume":"47","author":"Scott","year":"2010","journal-title":"Essays Biochem."},{"issue":"4","key":"10.1016\/j.mcn.2019.03.001_bb0350","doi-asserted-by":"crossref","first-page":"e1725","DOI":"10.1038\/cddis.2015.94","article-title":"Dynamin-related protein 1 is required for normal mitochondrial bioenergetic and synaptic function in CA1 hippocampal neurons","volume":"6","author":"Shields","year":"2015","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.mcn.2019.03.001_bb0355","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1432-1327.1999.00543.x","article-title":"Selective targeting of an antioxidant to mitochondria","volume":"263","author":"Smith","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.mcn.2019.03.001_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-007-1001-z","article-title":"The importance of \u03b2-carotene as a source of vitamin a with special regard to pregnant and breastfeeding women","volume":"46","author":"Strobel","year":"2007","journal-title":"Eur. J. Nutr."},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0365","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.mcn.2019.03.001_bb0370","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/clpt.2014.174","article-title":"Serendipity and the discovery of novel compounds that restore mitochondrial plasticity","volume":"96","author":"Szeto","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.mcn.2019.03.001_bb0375","doi-asserted-by":"crossref","first-page":"E521","DOI":"10.1208\/aapsj080362","article-title":"Mitochondria-targeted peptide antioxidants: novel neuroprotective agents","volume":"8","author":"Szeto","year":"2006","journal-title":"AAPS J."},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0380","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/bph.12461","article-title":"First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics","volume":"171","author":"Szeto","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2017","key":"10.1016\/j.mcn.2019.03.001_bb0385","first-page":"114","article-title":"The role of BDNF in Alzheimer's disease","volume":"97","author":"Tanila","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0390","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.mcn.2019.03.001_bb0395","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/1568026615666150827095102","article-title":"Relationships between mitochondria and Neuroinflammation: implications for Alzheimer's disease","volume":"16","author":"Wilkins","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.mcn.2019.03.001_bb0400","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.0959-9673.2005.00427.x","article-title":"Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD)","volume":"86","author":"Yan","year":"2005","journal-title":"Int. J. Exp. Pathol."},{"issue":"9","key":"10.1016\/j.mcn.2019.03.001_bb0405","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl 1(0 1)","key":"10.1016\/j.mcn.2019.03.001_bb0410","first-page":"S253","article-title":"Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease","volume":"33","author":"Zhu","year":"2013","journal-title":"Journal of Alzheimer's disease: JAD"}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743119300211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743119300211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:50:39Z","timestamp":1778795439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743119300211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":82,"alternative-id":["S1044743119300211"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2019.03.001","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecules as therapeutic drugs for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}